Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA).

Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives.

Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's parent company Alcidion Group (ASX:ALC).

MSD Lebanon is looking for an external partner to co-create a digital solution that helps oncologists to stay updated with relevant clinical content about cancer. The solution should consider several channels (web, app, email newsletter, social media, etc) and adapt to the preferences to each user, so they are motivated to access the content regularly over time.

A passenger suddenly has chest pain on board. The crew asks for a doctor; when present, this is not always a cardiologist. The pilot has to decide if a flight diversion is required or not. The dilemma: Despite having a doctor on board, crucial ECG information is missing. As more and more older people fly and the trend towards long-distance travel increases, medical emergencies on board become more common.

GenePlanet, the Swiss-backed biotech company present in more than 30 countries worldwide, is attending MEDICA, the leading international trade fair for the medical sector that takes place in Düsseldorf, Germany, from 12-15 November. "Our participation at MEDICA represents a great opportunity to introduce our solutions to a highly-qualified audience.

Scientists at the University of Sussex have developed a piece of hardware to demonstrate how our brains function, as part of a growing range of equipment which uses DIY and 3D printable models to open up access to science education. Professor of Neuroscience, Tom Baden, has been working with colleagues to build Spikeling; a piece of electronic kit which behaves similarly to neurons in the brain.